improving long-term outcomes in her2 breast cancer
Published 5 years ago • 38 plays • Length 5:39Download video MP4
Download video MP3
Similar videos
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
5:29
adding lapatinib to adjuvant trastuzumab doesn't improve outcomes in her2-positive breast cancer
-
1:25:12
a guide for selection, sequencing, and optimal use of her2-targeted therapies in her2 breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
2:38
options in breast cancer after her2 targeted therapy
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
32:54
raising the bar in her2-positive breast cancer
-
6:42
trastuzumab pertuzumab may improve pcr outcomes in her2-positive breast cancer patients
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
5:46
use of her2-targeted therapy in breast cancer
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
51:01
new & supporting data for optimizing therapy in her2 breast cancer | dr. traina & dr. carey